Director, Center for Advancement in Managing Pain
I am an educator and researcher with specialized training in pain, immunology, and behavioral pharmacology. My lab uses multidisciplinary tools, including pharmacological and genetic experimental animal models to study the opioid and endocannabinoid systems and how they control of pain, inflammation, addiction, anxiety, depression, and the neuroendocrine stress response. My goal, as principal investigator and mentor of a diverse team of graduate and undergraduate students, is to help develop interventions to improve pain management and reduce human suffering.
- Cannabinoid/opioid pharmacology
- Chronic pain
- Substance use disorders
- Ph.D., Behavioral Neuroscience, The Ohio State University
Honors & Awards
- 2019: Outstanding Researcher Award, West Virginia University
- 2011: Postdoctoral Best Abstract Award, American Society for Pharmacology and Experimental Therapeutics
- 2010: Trainee Scholarship, Psychoneuroimmunology Research Society
- 2007: Meritorious Teaching Award, The Ohio State University
* graduate mentee; ** undergraduate mentee
Nass*, SR, Steele*, F.F, and Kinsey, SG. (2021). MAGL inhibition attenuates inflammatory arthritis-induced paw inflammation. Cannabis and Cannabinoid Research. In Press.
Trexler*, KR, Vanegas*, SO, Poklis, JL, & Kinsey, SG (2020). The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice. Drug and Alcohol Dependence. 214:108179.
White, AN, Gross*, JD, Kaski*, SW, Trexler* KR, Wix, KA, Rodriguiz, RM, Wetsel, WC, Kinsey, SG, Siderovski, DP, Setola, V. (2020). Genetic deletion of Rgs12 in mice affects serotonin transporter expression and function in vivo and ex vivo. Journal of Psychopharmacology. 34:1393-1407.
Eckard*, M.L., Trexler*, K.R., Anderson, K.G., & Kinsey, S.G. (2020). Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice. Pharmacology, Biochemistry, and Behavior. 195:172966.
|Office Location||SH 112B|